您搜索了: tromber (丹麦语 - 英语)

antitrombotiske lægemidler forhindrer dannelsen af blodpropper (tromber).
antithrombotics are medicines which prevent the formation of blood clots (thrombosis).

ved at hæmme faktor xa forhindrer apixaban dannelsen af trombin og udviklingen af tromber.
by inhibiting factor xa, apixaban prevents thrombin generation and thrombus development.

4. 4 – venøse tromber såsom tromboflebit, dyb venetrombe og lungeemboli i relation hertil.
in the vast majority of cases the patients were predisposed to arterial thrombotic disorders either due to underlying disease, age, atherosclerotic or current medical conditions as described in section 4.4 – venous thrombotic events such as thrombophlebitis, deep vein thrombosis and hereto related pulmonary embolism.

hæmning af faktor xa afbryder blodkoagulationskaskadens intrinsiske og ekstrinsiske bane, og hæmmer både dannelsen af trombin og tromber.
inhibition of factor xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi.

alvorlige bivirkninger siden markedsføringen inkluderer: – arterielle tromber såsom myokardieinfarkter eller iskæmi, cerebrovaskulære lidelser og tarm infakt.
serious adverse reactions reported during the post-marketing period include: – arterial thrombotic events such as myocardial infarctions or ischaemia, cerebrovascular disorders and bowel infarction.

da trombin (serinprotease) fremmer ændringen af fibrinogen til fibrin i koagulationskaskaden, vil en hæmning af trombin forhindre udviklingen af tromber.
since thrombin (serine protease) enables the conversion of fibrinogen into fibrin during the coagulation cascade, its inhibition prevents the development of thrombus.

de alvorligste bivirkninger skal anføres først.alvorlige bivirkninger siden markedsføringen inkluderer: ­ arterielle tromber såsom myokardieinfarkter eller iskæmi, cerebrovaskulære lidelser og tarm infakt.
serious adverse reactions reported during the post-marketing period include: ­ arterial thrombotic events such as myocardial infarctions or ischaemia, cerebrovascular disorders and bowel infarction.

i langt de fleste tilfælde var patienterne disponerede for arterielle trombotiske lidelser enten grundet underliggende sygdom, alder, arteriosklerotisk eller nuværende sygdom som beskrevet i 4. 4 " særlige advarsler og forsigtighedsregler vedrørende brugen " ­ venøse tromber såsom tromboflebit, dyb venetrombe og lungeemboli i relation hertil.
in the vast majority of cases the patients were predisposed to arterial thrombotic disorders either due to underlying disease, age, atherosclerotic or current medical conditions as described in 4.4 " special warnings and precautions for use ". ­ venous thrombotic events such as thrombophlebitis, deep vein thrombosis and hereto related pulmonary embolism.